Darunavir 800mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tablets
NHS hospitals in England used £24,273,772 of indicative cost of Darunavir 800mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is down 0.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Darunavir 800mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Darunavir 800mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Manchester University Nhs Ft | £2,674,745 |
| Guy's & St Thomas' Nhs Foundation Trust | £1,683,449 |
| Royal Free London Nhs Foundation Trust | £1,628,379 |
| Barts Health Nhs Trust | £1,553,902 |
| King's College Hpl Nhs Foundation Trust | £1,437,475 |
| Imperial College Healthcare Nhs Trust | £1,262,615 |
| Chelsea & Westminster Hospital Nhs Ft | £1,207,543 |
| University College London Foundation Tr | £903,242 |
| St George's Univ Hosps Foundation Nhst | £836,510 |
| London North West Healthcare Nhs Trust | £748,350 |
The primary-care picture
Darunavir is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Darunavir medicine page.